Profiel
Cole Ikkala is currently the Head of Business Operations for the Neuroscience Group at Radius Health, Inc. Prior to this, he worked as the Director of Investor Relations and Communications at NVN Liquidation, Inc.
Actieve functies van Cole Ikkala
| Bedrijven | Functie | Begin |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01-07-2020 |
Eerdere bekende functies van Cole Ikkala
| Bedrijven | Functie | Einde |
|---|---|---|
| NVN LIQUIDATION, INC. | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |